Skip to main content
Industry News
Prophylactic therapy may cut CV risk for diabetes patients
9/25/2020

People with diabetes but not cardiovascular disease who took prophylactic CV medications had a 61% decrease in their risk for myocardial infarction and a 41% drop in their risk of death, according to a study presented at the virtual European Society of Cardiology Congress. Researcher Dr. Christine Gyldenkerne said other factors may have contributed to the reduced risks, including better diabetes control, smoking cessation, physical activity and healthier eating.

Full Story: